Ipca Laboratories Limited (BOM:524494)
India · Delayed Price · Currency is INR 1,488.55
+13.15 (0.89%)
At close: Feb 13, 2026
Ipca Laboratories Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | 7,377 | 5,474 | 4,713 | 8,841 | 11,400 |
Depreciation & Amortization | 3,913 | 3,494 | 2,539 | 2,257 | 2,035 |
Other Amortization | 64.8 | 78.4 | 76.3 | 67.4 | 57.1 |
Loss (Gain) From Sale of Assets | -27.6 | -38.5 | -160.5 | 0.3 | - |
Asset Writedown & Restructuring Costs | 1,168 | 9.3 | 28.4 | 113.6 | 187 |
Loss (Gain) From Sale of Investments | 1,504 | -614.5 | 13.8 | -27.8 | 5.3 |
Stock-Based Compensation | 20.6 | 30.6 | - | - | - |
Provision & Write-off of Bad Debts | 38 | 8.3 | 22.7 | 11.6 | 11.9 |
Other Operating Activities | 919 | 1,921 | 335 | 25.2 | -431.4 |
Change in Accounts Receivable | -2,177 | -758 | -681 | -802.4 | 967.5 |
Change in Inventory | -915.6 | -947 | 1,146 | -2,492 | -2,717 |
Change in Accounts Payable | 726.6 | 214.9 | -324 | -1,097 | 559.5 |
Change in Other Net Operating Assets | 601.1 | 574.2 | 348.9 | 1,664 | -1,173 |
Operating Cash Flow | 13,213 | 9,447 | 8,058 | 8,561 | 10,901 |
Operating Cash Flow Growth | 39.87% | 17.23% | -5.87% | -21.47% | 91.13% |
Capital Expenditures | -7,756 | -4,113 | -4,945 | -4,790 | -3,616 |
Sale of Property, Plant & Equipment | 53.3 | 86.2 | 361.5 | 28.4 | 25.7 |
Cash Acquisitions | - | -15,429 | -105.9 | -301.1 | - |
Investment in Securities | -334.5 | 396.7 | -453.4 | -3,917 | -1,501 |
Other Investing Activities | -658.1 | 6,121 | -2,177 | 429.1 | -116.2 |
Investing Cash Flow | -8,695 | -12,918 | -7,250 | -8,551 | -5,207 |
Short-Term Debt Issued | - | - | 2,943 | 1,933 | - |
Long-Term Debt Issued | 2,184 | 1,237 | 3,917 | 4,137 | 28.3 |
Total Debt Issued | 2,184 | 1,237 | 6,860 | 6,070 | 28.3 |
Short-Term Debt Repaid | -639.4 | -3,038 | - | - | -1,604 |
Long-Term Debt Repaid | -2,616 | -1,874 | -357.6 | -726 | -741.5 |
Total Debt Repaid | -3,255 | -4,913 | -357.6 | -726 | -2,345 |
Net Debt Issued (Repaid) | -1,072 | -3,676 | 6,502 | 5,344 | -2,317 |
Issuance of Common Stock | - | - | - | - | 358.1 |
Common Dividends Paid | -1,015 | -507.4 | -1,015 | -1,015 | -1,015 |
Other Financing Activities | -743.5 | -1,343 | -414.8 | -61.8 | -84.1 |
Financing Cash Flow | -2,830 | -5,526 | 5,072 | 4,268 | -3,058 |
Miscellaneous Cash Flow Adjustments | - | 765 | - | 41.2 | - |
Net Cash Flow | 1,688 | -8,232 | 5,881 | 4,319 | 2,636 |
Free Cash Flow | 5,458 | 5,334 | 3,113 | 3,771 | 7,286 |
Free Cash Flow Growth | 2.32% | 71.31% | -17.44% | -48.24% | 175.90% |
Free Cash Flow Margin | 6.10% | 6.92% | 4.98% | 6.47% | 13.44% |
Free Cash Flow Per Share | 21.51 | 21.02 | 12.27 | 14.87 | 28.77 |
Cash Interest Paid | 743.5 | 1,343 | 414.8 | 61.8 | 84.1 |
Cash Income Tax Paid | 3,613 | 2,963 | 2,237 | 2,020 | 2,456 |
Levered Free Cash Flow | -145.6 | -6,836 | 1,904 | 1,448 | 3,945 |
Unlevered Free Cash Flow | 381.4 | -5,978 | 2,186 | 1,493 | 3,999 |
Change in Working Capital | -1,765 | -915.9 | 489.9 | -2,727 | -2,363 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.